QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(IRS Employer Identification No.) | ||
|
||||
(Address Of Principal Executive Offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-fourth of one redeemable warrant |
||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
September 30, 2021 |
December 31, 2020 |
|||||||
(Unaudited) |
||||||||
Assets: |
||||||||
Current assets: |
||||||||
Cash |
$ | $ | — | |||||
Prepaid expenses |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
Investments held in Trust Account |
— | |||||||
Deferred offering costs associated with the initial public offering |
— | |||||||
|
|
|
|
|||||
Total Assets |
$ |
$ |
||||||
|
|
|
|
|||||
Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit): |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | — | |||||
Accrued expenses |
||||||||
Accrued expenses - related party |
— | |||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
Deferred underwriting commissions |
— | |||||||
Derivative warrant liabilities |
— | |||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
|||||
Commitments and Contingencies |
||||||||
Class A ordinary shares subject to possible redemption, $ - shares at $ |
— | |||||||
Shareholders’ Equity (Deficit): |
||||||||
Preference shares, $ |
— | |||||||
Class A ordinary shares, $ |
— | |||||||
Class B ordinary shares, $ |
||||||||
Additional paid-in capital |
— | |||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total shareholders’ equity (deficit) |
( |
) | ||||||
|
|
|
|
|||||
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) |
$ |
$ |
||||||
|
|
|
|
For the Three Months Ended September 30, 2021 |
For the Nine Months Ended September 30, 2021 |
|||||||
General and administrative expenses |
$ | $ | ||||||
General and administrative expenses - related party |
||||||||
Loss from operations |
( |
) | ( |
) | ||||
Other income (expenses): |
||||||||
Offering costs associated with derivative warrant liabilities |
— | ( |
) | |||||
Loss upon issuance of private placement warrants |
— | ( |
) | |||||
Change in fair value of derivative warrant liabilities |
||||||||
Income from investments held in Trust Account |
||||||||
Net income |
$ | $ | ||||||
Weighted average shares outstanding of Class A ordinary shares, basic and diluted |
||||||||
Basic and diluted net income per share, Class A ordinary shares |
$ | $ | ||||||
Weighted average shares outstanding of Class B ordinary shares, basic |
||||||||
Basic net income per share, Class B ordinary shares |
$ | $ | ||||||
Weighted average shares outstanding of Class B ordinary shares, diluted |
||||||||
Diluted net income per share, Class B ordinary shares |
$ | $ | ||||||
Ordinary Shares |
Additional |
Total |
||||||||||||||||||||||||||
Class A |
Class B |
Paid-in |
Accumulated |
Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Equity (Deficit) |
||||||||||||||||||||||
Balance - December 31, 2020 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
Accretion of Class A ordinary shares subject to redemption |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Balance - March 31, 2021 (unaudited) |
( |
) |
( |
) | ||||||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance - June 30, 2021 (unaudited) |
— |
( |
) |
( |
) | |||||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance - September 30, 2021 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
Cash Flows from Operating Activities: |
||||
Net income |
$ | |||
Adjustments to reconcile net income to net cash used in operating activities: |
||||
General and administrative expenses paid by related party under promissory note |
||||
Loss upon issuance of private placement warrants |
||||
Offering costs associated with derivative warrant liabilities |
||||
Change in fair value of derivative warrant liabilities |
( |
) | ||
Income from investments held in Trust Account |
( |
) | ||
Changes in operating assets and liabilities: |
||||
Prepaid expenses |
( |
) | ||
Accounts payable |
||||
Accrued expenses |
||||
Accrued expenses - related party |
||||
Net cash used in operating activities |
( |
) | ||
Cash Flows from Investing Activities: |
||||
Cash deposited in Trust Account |
( |
) | ||
Net cash used in investing activities |
( |
) | ||
Cash Flows from Financing Activities: |
||||
Repayment of note payable to related party |
( |
) | ||
Proceeds received from initial public offering, gross |
||||
Proceeds received from private placement |
||||
Offering costs paid |
( |
) | ||
Net cash provided by financing activities |
||||
Net increase in cash |
||||
Cash - beginning of the period |
||||
Cash - end of the period |
$ |
|||
Supplemental disclosure of noncash investing and financing activities: |
||||
Offering costs included in accrued expenses |
$ | |||
Offering costs paid by related party under promissory note |
$ | |||
Deferred underwriting commissions |
$ |
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
For the Three Months Ended |
For the Nine Months Ended |
|||||||||||||||
September 30, 2021 |
September 30, 2021 |
|||||||||||||||
Class A ordinary |
Class B ordinary |
Class A ordinary |
Class B ordinary |
|||||||||||||
shares |
shares |
shares |
shares |
|||||||||||||
Basic net income per ordinary share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income |
$ | $ | $ | $ | ||||||||||||
Denominator: |
||||||||||||||||
Basic weighted average ordinary shares outstanding |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic net income per ordinary share |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
For the Three Months Ended |
For the Nine Months Ended |
|||||||||||||||
September 30, 2021 |
September 30, 2021 |
|||||||||||||||
Class A ordinary |
Class B ordinary |
Class A ordinary |
Class B ordinary |
|||||||||||||
shares |
shares |
shares |
shares |
|||||||||||||
Diluted net income per ordinary share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income |
$ | $ | $ | $ | ||||||||||||
Denominator: |
||||||||||||||||
Diluted weighted average ordinary shares outstanding |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted net income per ordinary share |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
• | in whole and not in part; |
• | at a price of $ |
• | upon a minimum of |
• | if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $ |
• | in whole and not in part; |
• | at $ |
• | if, and only if, the closing price of Class A ordinary shares equals or exceeds $ |
• | if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. |
Gross proceeds from Initial Public Offering |
$ | |||
Less: |
||||
Fair valu e of Public Warrants at issuance |
( |
) | ||
Offering costs allocated at Class A ordinary shares subject to possible redemption |
( |
) | ||
Plus: |
||||
Accretion on Class A ordinary shares subject to possible redemption |
||||
|
|
|||
Class A ordinary shares subject to possible redemption |
$ | |||
|
|
Fair Value Measured as of September 30, 2021 |
||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets: |
||||||||||||||||
Investments held in Trust Account - money market funds |
$ | $ | — | $ | — | $ | ||||||||||
Liabilities: |
||||||||||||||||
Derivative warrant liabilities - public warrants |
$ | $ | — | $ | — | $ | ||||||||||
Derivative warrant liabilities - private warrants |
$ | — | $ | — | $ | $ |
As of September 30, 2021 |
|||||
Share price |
$ | ||||
Exercise price |
$ | ||||
Option term (in years) |
|||||
Volatility |
% | ||||
Risk-free interest rate |
% | ||||
Expected dividends |
% |
Derivative warrant liabilities at January 1, 2021 |
$ | |||
Issuance of Public and Private Warrants |
||||
Change in fair value of derivative warrant liabilities |
( |
) | ||
|
|
|||
Derivative warrant liabilities at March 31, 2021 |
||||
Transfer of Public Warrants to a Level 1 measurement |
( |
) | ||
Change in fair value of derivative warrant liabilities |
( |
) | ||
|
|
|||
Derivative warrant liabilities at June 30, 2021 |
||||
Change in fair value of derivative warrant liabilities |
( |
) | ||
|
|
|||
Derivative warrant liabilities at September 30, 2021 |
$ | |||
|
|
* | Filed herewith. |
** | These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
Dated: November 15, 2021 | ARCTOS NORTHSTAR ACQUISITION CORP. | |||||
By: | /s/ John Vedro | |||||
Name: | John Vedro | |||||
Title: | Chief Financial Officer and Authorized Signatory |